IRF3 and systemic sclerosis: Indeed, the significance of the IRF-3 pathway has been reported for inflammation-related diseases such as rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, inflammatory bowel disease, chronic obstructive pulmonary disease, and type II diabetes [9,12,13].